Bitcoin

The revival of antimicrobial research signals deeper systemic vulnerabilities in global health infrastructure, which may accelerate demand for decentralized solutions (e.g., blockchain-based drug traceability or decentralized biotech R&D funding). This aligns with crypto's long-term value proposition as infrastructure for resilient systems, though current market conditions ignore such second-order effects.

Scientists are reviving antimicrobial peptides to combat drug-resistant bacteria.